Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Jonsson Comprehensive Cancer Center
- Study ID
- NCT04742608
- Status
- Recruiting
Conditions
- Thyroid Gland Carcinoma
- Thyroid Gland Nodule
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Biospecimen Collection — PROCEDUREUndergo collection of blood and tissue samples
- Electronic Health Record Review — OTHERMedical charts are reviewed
Study Details
This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood and tissues samples may also help researchers to differentiate non-cancerous tumors from thyroid cancer and detect high-risk mutations to guide treatment.
Key Dates
- Start date
- Feb 21, 2020
- Status verified
- Mar 2026
- Primary completion
- Jun 9, 2025
- Completion
- Feb 1, 2027
Study Design
- Enrollment
- 250 participants (estimated)
Arms
- Arm: Ancillary-correlative (biospecimen collection)Patients undergo collection of blood samples on the day of surgery following anesthesia but prior to incision and at the first routine blood test following surgery. Patients who undergo remnant ablation after total thyroidectomy with radioactive iodine have an additional blood sample collected. Patients also undergo collection of tissue samples following surgical resection of thyroid nodule or thyroid cancer. Patients' medical records are also reviewed.
Primary Outcome Measure
Sensitivity of molecular profile of thyroid-derived extracellular vesicles [ Time Frame: Up to 3 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCLA / Jonsson Comprehensive Cancer Center | Los Angeles | California | 90095 | James Wu (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid NodulesRecruiting · City of Hope Medical Center · Duarte, California
- Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid NodulesRecruiting · City of Hope Medical Center · Duarte, California
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruiting · Alliance for Clinical Trials in Oncology · Anchorage, Alaska
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersPHASE1 · Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California